NanoViricides, Inc.
corporate_fare Company Profile
NanoViricides, Inc. (NYSE:NNVC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 2 items for NNVC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-17, rated 7/10. Across its 2 most recent items scored 7 or higher, the top rating is 8/10, with 1 rated 8 or above. Recent SEC coverage for NNVC spans 424B5, 10-Q.
Recent high-impact activity:
- NanoViricides Refreshes ATM Capacity to $8.4M Under S-3 Float Cap
- NanoViricides Q1 Loss Widens to $5.7M; Going-Concern Doubt and ATM Sales Begin
Financial Snapshot
Short Interest & Short Volume
4.19 days to coverFINRA reported short interest of 812,252 shares in NNVC as of the October 30, 2026 settlement, a 28.9% decrease from the prior period — about 4.2 days to cover at its recent average daily volume. On November 20, 2026, 31.8% of NNVC volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for NNVC, detected from its recent SEC filings · based on capital-structure filings through 2026-11-17.
ATM Capacity Reset to $8.4M · Float Cap Drives the Limit
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →